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provides opportunity to intervene. Interventions must account for limited
resources available in many regions with the highest resistance burdens. In
response to this we launched the Viet Nam Resistance (VINARES) project, a
capacity-building initiative designed to strengthen antimicrobial steward-
ship in Viet Nam. The framework of VINARES may be transferable to other
settings, and emerging economies in particular. During my talk I will present
our findings during the VINARES project.
Summary Points
 Antimicrobial stewardship has been difficult to implement globally, and
in emerging economies it is usually absent or inadequate.
 Implementation of antibiotic stewardship programmes need not wait
for “perfect local data” or funding. There is often sufficient local
expertise to start a programme in the absence of additional resources.
No immediate impact on resistance levels should be expected.
 Antibiotic resistance is partly the result of a dysfunctional health sys-
tem. Long-term commitment is necessary to improve healthcare infra-
structure in order to establish a successful antibiotic stewardship
programme and reduce resistance rates.
 Healthcare professionals, preferably “respected” figures, should coor-
dinate stewardship programmes. The programmes should be contex-
tualised and compatible with local practices to encourage
engagement and compliance of all healthcare workers.
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DOSE CVC CARE BUNDLE WORK IN CENTRAL LINE ASSOCIATED BLOOD
STREAM INFECTION (CLABSI)? e TAKE TAIWAN AS AN EXAMPLE
Chun-Ming Lee, MD. PhD. Division of Infectious Diseases, Department of
Internal Medicine, Infection Control Center, Mackay Memorial Hospital,
Taipei, Taiwan; Chairman of infection Control Society of Taiwan, Taiwan
Central line associated bloodstream infection (CLABSI) is an important issue in
healthcare associated infection (HAI). Theuse of catheter is an inevitable device
in hospital. According to the data of Taiwan Nosocomial Infection Surveillance
(TNIS), bloodstream infection ( BSI )is one of the most common HAI in intensive
care unit (ICU) and above 70% are associated with the use of catheter. This
presentation is to show the result of central venous catheter (CVC) care bundle
campaign in preventing CLABSI in the past four years in Taiwan.
The CVC care bundle campaign had two stages .The first stage belonged to
pilot study that initiated from 2010 to 2012. There were 26 ICU with 432 beds
from 14 hospitals of different areas of Taiwan. The second stage was called
promoted stage, started from 2013 to 2014 that included 50 hospitals with
133 ICU and 1900 beds. The data collection of CLABSI rate included before
and after CVC care bundle intervention. The contents of CVC care bundle
included 5 elements and two checklists of insertion and daily care of CVC.
The definition of CLABSI is at least one significant positive blood culture with
central catheter in situ or within 48 hours after catheter removing and had
to exclude the secondary BSI.
The CLABSI rate in the pilot study was 5.810/00 and 5.16
0/00 before and af-
ter intervention with 11.2% reduction only. The result showed 46 CLABSI
were avoided and it estimated 23,000 USD medical cost was saved (Ex-
tra-medical cost is about 5,000 USD per one CLABSI in Taiwan). At the sec-
ond stage the CLABSI rate was declined from 5.610/00 to 3.33
0/00 before
and after 19 months intervention with 40.6% reduction. The result showed
643 CLABSI were avoided and it estimated 3,215,000 USD medical cost was
saved.
Currently, there are some evidence based guidelines concerning the good
prevention of CLABSI by CVC care bundle (usually decreased 40e60%). Our
result 40.6% is approached to the low margin that reported by the
references. The important reasons are the compliance and consistency to
the care bundle is not so satisfactory that included the high femoral site
insertion, failure to scrub the hub in sufficient time and also high CVC
utilization rate. These will be emphasized in the further CVC quality
promotion campaign when more hospitals will be recruited.Keyword: Intensive care unit, central venous catheter, central line associ-
ated infection, care bundle
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USE OF CHLORHEXIDINE TO PREVENT SURGICAL SITE INFECTIONS
Keita Morikane. Division of Clinical Laboratory and Infection Control,
Yamagata University Hospital, Yamagata, Japan
The effectiveness of chlorhexidine (CHG) over iodophor (IP) has been
extensively investigated and demonstrated for the prevention of catheter-
associated bloodstream infection. However, its effectiveness toward the
prevention of surgical site infection (SSI) is controversial.
Numerous researches have been performed to address this profound
question to perform the meta-analysis. However, there are many barriers
which prevent us from doing it. First, there are many types of antiseptics
available for preoperative skin preparation: CHG, CHG-alcohol, aqueous
IP, IP-alcohol, etc. with various concentrations (0.5%, 1%, 2%, etc.).
Second, the effectiveness of specific skin preps is expected to vary
depending on the type of operation, i.e, whether it is a clean surgery of
clean-contaminated one. Third, the outcomes of the studies are different
from each other, i.e., whether it is incisional SSI only, or incisional and
organ space SSI.
The Writing Committee of the Updated CDC/HICPAC SSI Prevention Guideline
carefully examined the available evidence with regard to this area, and did
the systematic review and analysis comparing CHG with IP by adjusting other
factors such as addition of alcohol and number of prep-steps. Their review
resulted in hardly any difference in comparison of CHG with IP. The
drawback of their review is that they did not separate clean surgery and
clean-contaminated surgery.
Noorani et al. did the meta-analysis using data from the clean-contaminated
surgery (Noorani A, et al. Br J Surg 2010;97:1614-20), and found that CHG is
superior to IP in preventing SSI (OR 0.68, 95% CI: 0.50-0.94). However, the
addition of alcohol to the antiseptics varied among the studies included in
this meta-analysis.
Further study is needed to examine the effectiveness of CHG over IP.SP 22-3
PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA
Glenys Harrington, RN, RM. Infection Control Consultancy (ICC), Melbourne,
Australia
Ventilator associated pneumonia (VAP) is associated with significant mor-
tality, increased length of stay and increased costs of care.
While the true incidence of VAP has been difficult to establish due to
surveillance definitions and methods and other serious complications
associated with mechanical ventilation such as acute respiratory distress
syndrome, it is estimated that up to fifty-five percent of VAP cases may be
preventable with the implementation of current practice guidelines/
recommendations.
In the US it has been estimated that if best practices were applied in all
hospitals the number of avoidable/preventable VAP infections would range
from 95,526 - 137,613 per annum and that 13,667 - 19,782 lives could be
saved.
Current basic practice guidelines/recommendations in the adult settings
include; avoiding intubation if possible, minimising sedation, maintaining
and improving physical conditioning, minimising pooling of secretions above
the endotracheal tube cuff, elevation of the head of the bed and
maintenance of ventilator circuits. In addition there are special approaches
or interventions in the settings where a hospital VAP rates are not reducing
despite demonstrated high compliance with basis practices. These addi-
tional approaches may have insufficient data at this point in time to
determine the impact on mortality, duration of mechanical ventilation and
length of stay.
Strategies to implement guidelines/recommendations including the “four
Es”; engagement, education, execution and evaluation will be discussed
along with current practice guidelines/recommendations to improve their
use at the bedside.
